215 related articles for article (PubMed ID: 15878878)
1. Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.
Xu XM; Zhou YQ; Wang MH
J Biol Chem; 2005 Jul; 280(26):25087-94. PubMed ID: 15878878
[TBL] [Abstract][Full Text] [Related]
2. Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
Wang MH; Lao WF; Wang D; Luo YL; Yao HP
Cancer Biol Ther; 2007 Jul; 6(7):1121-9. PubMed ID: 17611409
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
Danilkovitch-Miagkova A; Miagkov A; Skeel A; Nakaigawa N; Zbar B; Leonard EJ
Mol Cell Biol; 2001 Sep; 21(17):5857-68. PubMed ID: 11486025
[TBL] [Abstract][Full Text] [Related]
4. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
6. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
7. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW
J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732
[TBL] [Abstract][Full Text] [Related]
9. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
[TBL] [Abstract][Full Text] [Related]
11. Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase.
Yao HP; Luo YL; Feng L; Cheng LF; Lu Y; Li W; Wang MH
Cancer Biol Ther; 2006 Sep; 5(9):1179-86. PubMed ID: 16880737
[TBL] [Abstract][Full Text] [Related]
12. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C
Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of Wnt signaling factors in mouse brain.
Coyle-Rink J; Del Valle L; Sweet T; Khalili K; Amini S
Cancer Biol Ther; 2002; 1(6):640-5. PubMed ID: 12642687
[TBL] [Abstract][Full Text] [Related]
14. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
[TBL] [Abstract][Full Text] [Related]
15. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
Morrison JA; Klingelhutz AJ; Raab-Traub N
J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Lee YK; Lin TH; Chang CF; Lo YL
PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell proliferation through TGF-β receptor II (TGFRII)-Akt-β-catenin signaling.
Cheng L; Zhang C; Li D; Zou J; Wang J
Int J Mol Sci; 2014 Jul; 15(7):12665-76. PubMed ID: 25036031
[TBL] [Abstract][Full Text] [Related]
20. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
Dar AA; Belkhiri A; El-Rifai W
Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]